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Abstract The Interaction of calf-thymus DNA with aspirin is 
Investigated In aqueous olution at pH 7-6 with drug/DNA(phos- 
pbate) molar ratios of r = 1/40, 1/20, III0, 115, 112, I and 2. 
Fourier transform Infrared (FTIR) and laser Raman difference 
spectroscopy are used to determine drug binding sites, sequence 
preference and DNA secondary structure, as well as the 
structural variations of asplrin-DNA complexes in aqueous 
solution. Spectroscopic evidence showed that at low aspirin 
concentration (r = 1/40), drug-DNA interaction is mainly 
throngh the backbone PO~ groups and the A.T base pairs. Such 
intentetlon larply perturbs the phosphate vibration at 1227, 
cm -I end the A-T bands at 1663 and 1609 em -t with no major 
helix des~bllizatlon. At higher drug concentration (r > 1120), 
the participation of the G-C bases in dmg.DNA complexation 
was evident by strong perturbations of the guanine and cytosine 
vibratious at 1717 and 1494 em -t, with a partial helix 
destubilLmtion. A major alteration of the B-DNA structure 
towards A-DNA occurs on drug eomplexation. The aspirin 
interaction was through anion CO and COOCHs donor atoms 
with those of the backbone PO2 group and DNA bases donor 
sites (directly or indirectly via I"!20 molecules). 
cificity, helical stability and DNA secondary structure in 
aqueous solution. Vibrational spectroscopy (Raman and in- 
frared) is often used to characterize the nature of drug-DNA 
interaction and to monitor the effects of various drugs on 
DNA structure [7-9]. Recently, we applied vibrational spec- 
troscopy to analyse the nature of vitamin C complexatioa 
with calf-thymus DNA at physiological pH and different 
drug concentrations [I0]. This study allowed us to determine 
the drug binding sites, the sequence specificity, the DNA sec- 
ondary structure and the helical stability, in aqueous olution. 
We believe that vibrational spectroscopy can also be used 
here, in order to investigate the complex formation between 
DNA and aspirin and to elucidate the nature of this biologi- 
cally important drug-DNA interaction. 
In this communication, we report the interaction of calf- 
thymus DNA with aspirin in water/methanol (75:25, v/v) 
solution at pH 7-6 with aspirinlDNA(P) molar ratios r = II 
40 to 2, using FTIR and laser Raman spectroscopic techni- 
ques, that have not been previously reported. 
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I. Introduction 
Aspirin is an old drug, which falls into the category of the 
non-steroidal nti-inflammatory drugs (NSAID) and it is used 
extensively as a painkiiler, In recent years, aspirin was found 
to reduce the risk of heart attack and stroke. Aspirin is also 
suggested to be effective against colorectal cancer, while it has 
no effect on other types of cancers uch as lung, breast, ovary, 
testis, lymphoma nd leukemia [I-5], The exact mechanism by 
which aspirin exerts its anticancer activity is not clear. How- 
ever, NSAID drugs are found to block the synthesis of pros- 
tnglandins long chain fatty acid compounds that have various 
functions, including stimulation of cel~ proliferation and sup- 
pr~sion of immune reaction, both of which are linked to 
tumor proton .  Recently, the structural basis of the aspir- 
in activity inferred from the crystal structure of the inactivated 
prostaglundin H2 synthetase was reported [6]. If aspirin exhi- 
bits anticancer activity, its reaction with cell particles uch as 
nucleic acids, DNA polymerases, and proteins is of great bio- 
logical importance. In view of the biochemical ctivities of the 
aspirin, we were prompted to investigate the aspirin-DNA 
interaction and to determine drug binding site, sequence spa- 
*Com:sponding author. 
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2. Materials and methods 
Highly polymerized calf-thymus DNA sodium salt (7% Na content) 
was purchased from Pharmacia nd used as supplied. Aspirin was 
from Aldrich Chemical Co., and used without further purification. 
2. I. Preparation of stock solutions 
Na-DNA was dissolved to 4% w/w, 0.I M DNA(phosphate) in 0. I 
M NaCI solution at 5°C for 24 h with occasional stirring to ensure the 
formation of homogeneous solution. Solutions of aspirin 1.2 to I00 
mM were also prepared in water/methanol mixture (75:25, v/v) 
(methanolic solution was used to dissolve aspirin). In the final step, 
the appropriate amount of drug solution was added ropwise to DNA 
solution with constant stirring to give the desired rug/DNA molar 
ratios of 1/40, 1/20, III0, I/4, I/2, I and 2 at a final DNA concentra. 
tion o f  2% wlw or 0.05 M DNA(phosphate). Solution pH was ad- 
justed to 7-6, with 0. I M NaOH or HCI. 
Infrared spectra were recorded on a Bomem DA3-0.02 Fourier 
Transform infrared instrument, equipped with a nitrogen cooled 
HgCdTe detector and KBr beam splitter. Solution sgectra were taken 
using AgBr windows with resolution of 2 cm -t and 100 to 500 scans. 
The H20 subtraction was carried out as reported [! !]. A good sub- 
traction of water was achieved as shown by a flat baseline around 
2200 cm -t, where the water combination mode is located. The differ- 
ence spectra [(DNA solution + aspirin solution)- (DNA solution)] 
were obtained, using the band at 968 cm -~ as internal standard. 
This band due to the deoxyribose C-C stretching modes, exhibits no 
spectral changes (intensity or shifting) on drug-DNA interaction and 
is cancelled, upon spectral subtraction. 
Raman spectra were recorded on a DILOR Omars.89 Raman spec- 
trometer, using 514.4 nm line of an argon laser (Spectra-Physics, 
Model 2020-30). The laser power was 300 mW at the sample. The 
spectra were typically recorded at 5 cm -t slit width with a 2 s inte- 
gration time at each 2 cm -t frequency increment. They were routinely 
background-corrected by subtracting appropriate third-degree poly- 
nominal function from original curve. The spectra reproduced here 
are not smoothed. The Raman difference spectra [(DNA solution + 
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SSD! S00 ! 4 -5793(96)00093.2  
J.E Neault et al.IFEBS Letters 382 (1996) 26-30 27 
7 
E 
O 
W 
M < 
UJ 
0 
v- ,8~ +''- . I 
ASPIFIIN FREE "' "~'V'~ I 
/ 
I l e |  0 $ | .1140 " 
I e,,. Ilil .. I - ' ; - 'm i '~  " - I a '  V*~A8P~NAIP) 
i . " ' "  , 
1800 1400 1000 600 
WAVENUMBER (©m "1) 
Fig. 1. FTIR spectra (top four curves) and difference spectra (bot- 
tom three curves) [(DNA solution + aspirin solution) - (DNA solu- 
tion)] for the uncomplexed calf-thymus DNA and its aspirin com- 
plexes at pH 7-6 with different drug concentrations (drug/DNA(P) 
molar ratios) in the region of 1800-600 cm -]. 
aspirin solution)- (DNA solution)] were produced according to our 
previous report [12], using the intrense Raman line at 787 cm -1 as 
internal reference. This band due to the coupling of cytosine and 
phosphodiester modes, exhibits no spectral changes (intensity and 
shifting) on aspirin-DNA complexation and is cancelled, on spectral 
subtraction. 
The calculated intensity ratios of several prominent DNA in-plane 
vibrations (normalized against he band at 968 cm -1) were measured 
as a function of aspirin concentration with error of + 5%. The results 
from calculated intensity were used to quantify the amounts of drug- 
POz interaction versus drug-base binding. 
3. Results and discussion 
3.1. Aspirin-DNA complexes 
At low aspirin concentration (r = 1/40), drug binding is 
mainly through the backbone PO2 group and the A-T bases. 
Evidence for this comes from major intensity increase and 
shifting of the infrared bands at 1222 cm -] (PO2 antisym- 
metric stretch) and at 1663 cm -] (mainly thymine) and 1609 
cm -1 (mainly adenine) [I 1-19]. The intensity increase of these 
vibrations is also associated with the shift of the bands at 1663 
to 1664 cm- ], at 1609 to 1605 cm-I and 1222 to 1219 cm-] 
(Figs. 1 and 2). The calculated intensity ratios of several DNA 
in-plane vibrations (related to A,T,G,C bases and the back- 
bone PO2 groups) as a function of aspirin concentration are 
presented in Fig. 2. The observed spectral changes are due to 
the drug-DNA interaction via backbone phosphate group and 
the thymine 0-2 and adenine N-7 atoms, that are not nor- 
mally involved in Watson-Crick hydrogen bonding network. 
Such interaction does not bring about helix destabilization. It 
is important o note that, although the band at 1717 cm -] 
(G,T) shifted towards a lower frequency at 1710 cm -], no 
intensity variation is observed for this frequency, upon drug 
interaction (Figs. 1 and 2, r = 1/40). This is indicative of no 
major aspirin interaction via G-C base pairs at this stage. The 
shift of the infrared marker band at 1717 cm-] (G,T) towards 
a lower frequency is associated with a partial biopolymer con- 
formationai conversion, which will be discussed further on. 
To support drug binding to the backbone PO2 and the A-T 
rich region of the biopolymer, the Raman spectra of the as- 
pirin-DNA complexes are also examined here. The major gua- 
nine lines at 1491 cm -1 (G) and 1581 cm -1 (G), in the Raman 
spectrum of the uncomplexed DNA [13], exhibited no major 
spectral changes (shifting or intensity variations) on drug 
complexation, while the mainly adenine and thymine lines at 
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Fig. 2. The calculated intensity ratios of several DNA in-plane vi- 
brations (cm -l) as a function of aspirin concentration (ditferent asp/ 
DNA(P) molar ratios). 
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Fig. 3. Laser Raman spectra (top four curves) and difference spectra 
{bottom two curves) [(DNA solution) + aspirin solution-(DNA so- 
lution)] for uncompleted calf-thymus DNA and its aspirin com- 
plaos at pH 7--6 with different drug concentrations (drug/DNA(P) 
molar atios) in the region of 1800-500 cm -I. 
1342 (A), 1304 (A) 1661 (T) and 1376 cm -1 (T,A) shifted 
towards higher frequencies at 1344, 1306, 1670 and 1376 
cm -1, respectively, on drug complexation (Fig. 3, r = 1/40). 
Similarly, the PO2 line at 1093 cm -~ is observed at 1095 cm -~, 
in the spectra of the aspirin-DNA complexes (Fig. 3). The 
observed Raman spectral changes prove the existence of a 
major drug-DNA interaction through backbone phosphate 
and the A-T base pairs (H-bonding via H20). In the infrared 
and Raman difference spectra of the drug-DNA complexes 
with r = 1/40, several weak positive derivative features are 
observed at 1590 (DNA), 1487 (DNA), 1189 (asp), 951 (asp) 
and 851 cm -1 (asp), that are mainly due to the aspirin anion 
and DNA vibrational frequencies (Figs. 1 and 3). The calcu- 
lated intensity ratios of the infrared bands at 1222 cm -1 (PO2 
stretch) and at 1663 and 1609 cm -1 (T and A vibrations) 
show almost similar amounts of drug-PO2 and drug-base 
bindings (15%) at this stage (Fig. 2). 
At r --" 1/20, a minor reduction of intensity is observed for 
DNA in-plane vibrations at 1717, 1663, 1609, 1494 and 1222 
cm -t (Fig. 2). The PO2 band at 1222 cm -t shifted towards a 
higher frequency at 1225 cm -t, while the IR marker band at 
1717 (G,T) shifted to 1710 cm -l (Fig. 1). Similarly, the loss of 
intensity and shifting of the marker infrared band at 841 cm-l 
(O-P-O mode) to a lower frequency at 835 cm -~ occurred, in 
the infrared spectra of aspirin-DNA complexes (Fig. 1). The 
observed spectral changes are attributed to a partial reduction 
of B-DNA structure towards A-DNA conformation, upon 
drug complexation [19]. Similarly, the loss of intensity and 
shifting of the Raman marker line at 839 cm -1 (phosphodi- 
ester mode) [13] to a lower i'requency at 828 cm -1 are due to a 
reduction of the B-DNA structure towards A-DNA formation 
(Fig. 3). It is important o note, that previous tudies have 
indicated that the oxoanion with strong affinity towards H- 
bond formation with DNA donor sites or water of hydration, 
in the grooves of the helix, can stabilize a particular confor- 
mation over other structures [16]. Thus, the interaction of the 
aspirin anion with the water of hydration around DNA bases 
and the backbone sugar-phosphate moieties alters the activity 
of water and stabilizes ome degree of A-DNA conformation. 
In a recent study by Loprete and Hartman [20] it is also 
shown that organic and inorganic anions can alter the second. 
ary structure of the synthetic DNAs in many ways, by altering 
the water structures around DNA bases and the backbone 
phosphate groups and stabilizing certain DNA conformation. 
At r > 1/20, aspirin interaction with guanine bases occurs. 
Evidence for this comes from an increase in the intensity of 
the band at 1717 cm -1 which is related mainly to the guanine 
vibration (Fig. 2), Similar increase in intensity is also observed 
for the PO~ band at 1222 cm -l (Fig. 2). However, the mainly 
cytosine band at 1494 cm -~ exhibits no major intensity varia- 
tions or shifting, upon drug interaction. The observed changes 
are due to a major drug interaction with the phosphate group 
and the guanine bases (N-7 site) with no perturbation of the 
cytosine residues. Evidence for the guanine participation in 
drug interaction comes also from the shift of the guanine lines 
at 1491 and 1581 cm -~ towards lower frequencies, in the Ra- 
man spectra of the aspirin-DNA complexes formed at r > 1/ 
20 (Fig. 3). However, this type of complexation with the gua- 
nine bases does not also cause helix destabilization, since no 
major increase of intensity is observed for the DNA in-plane 
vibrations [13]. 
At r > 1/10, drug-DNA interaction continues through ade- 
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nine, thymine and guanine bases as well as the backbone PO2 
groups with no major participation of the cytosine bases. 
Evidence for this comes from an intensity increase of the 
infrared bands at 1717 cm-: (G,T), 1662 cm -1 (T,G,A,C), 
1609 cm -1 (A) and 1222 cm -1 (PO2), while the mainly cyto- 
sine bands at 1494 and 1529 cm -1 exhibit no intensity varia- 
tions, upon aspirin interaction (Fig. 2). The positive derivative 
features observed at 1707, 1660, 1595, 1383, 1240 and 1089 
cm -1, in the infrared difference spectra of drug-DNA com- 
plexes, are also related to a major intensity increase of the 
DNA bases and the PO2 vibrational frequencies, as a result 
of a strong aspirin-DNA interaction (Fig. 1, r = 1/5). Simi- 
larly, the Raman lines at 1661 cm -1 (T), 1581 and 1491 cm -1 
((3), 1376 cm -1 (T,A), 1342 and 1304 cm -1 (A)and  1093 
¢m -1 (PO2) exhibit shiftings and intensity changes, while the 
Raman band at 1257 cm -1, due to cytosine mode [13], shows 
no alterations on aspirin complex formation (Fig. 3). The 
calculated intensity ratios of DNA in-plane vibrations, related 
to the A,T,G and PO2 modes, show major drug-base binding 
(30%) with respect o drug-PO2 interaction (20%) (Fig. 2). 
At r = 112, drug-DNA binding to cytosine bases also occurs 
with major alteration of the cytosine vibrational frequencies. 
Evidence for this comes from a major intensity increase and 
shifting of the mainly cytosine bands at 1529 to 1534 cm -1 
and 1494 to 1488 cm -x (Fig. 1,2, r = 1). Similarly, the Raman 
line at 1257 cm -1 (C) gains intensity and shifts towards a 
lower frequency at 1255 ¢m -1 (Fig. 3, r = 1). The drug- 
DNA bindings through A-T and G-C base pairs continue 
up to r=l, where major increase of intensity is observed for 
the infrared bands at 1717 (G,T), 1663 (T,A,G,C), 1609 (A), 
1494 (C) and 1222 cm -1 (PO2) (Fig. 2). The presence of sev- 
eral positive derivative features at 1717, 1660, 1508, 1220 and 
1090 cm -1, in the infrared difference spectra of the aspirin- 
DNA complexes, is also due to a considerable intensity in- 
crease of DNA bases and phosphate vibrational frequencies, 
as a result of drug-DNA interaction (Fig. 1, r = 1). Similarly, 
a major increase in intensity and shifting of the Raman lines 
at 1661 cm -1 (T)to 1673, 1589 cm -1 (G)to 1579, 1491 cm -1 
(G) to 1484, 1376 cm -t (T,A)to 1380, 1342 cm -] (A)to 1340 
and 1257 cm -1 (C) to 1255 occurs in the spectra of the aspir- 
in-DNA complexes (Fig. ~, r = 1). These spectral changes are 
also consistent with the strong positive derivative features 
observed at 1563, 1452, 1393, 1322, 1246 and 1204 cm -1, in 
the Raman difference spectra of the drug-DNA complexes 
(Fig. 3, r = 1). The calculated intensity ratios of the DNA 
vibrations exhibit an increase in drug-base binding (40%), 
while the aspirin-POa interaction shows no major alteration 
(30°/o), as drug concentration i creases (Fig. 2). 
At r = 2, the aspirin-DNA interaction causes helix destabi- 
lization. Evidence for this comes from major intensity increase 
of several DNA in-plane vibrations and the shifting of the 
DNA marker bands at 1717 cm -1 (G,T) to 1696, 1663 cm -1 
(T,G,A,C) to 1656, 1494 cm -1 (C,G)to 1484, 1298 cm -1 
(C,A) to 1306, 1088 cm -1 (PO2) to 1090 (spectra is not 
shown). Similar partial helix destabilization is also observed 
for the ascorbate-DNA complexes formed at r > 1 [10]. The 
helix perturbation induced by aspirin is more pronounced 
than those associated with the ascorbate anion at high drug 
concentration [10]. However, by comparing the spectral al- 
terations of the calf-thymus DNA in the presence of H + 
and Cu cations (fully melted) and aspirin (partially destabi- 
lized), the observed intensity increases of certain DNA in- 
plane vibrations (marker bands) are larger (fourfold) for pro- 
ton and copper cations, than those of the aspirin-DNA com- 
plexes (twofold) [21,22]. It is worth mentioning, that the rea- 
son for the structural dependency of aspirin-DNA complexes 
on drug concentration is mainly related to different ypes of 
drug-DNA complexes, formed (with different DNA binding 
sites) as aspirin concentration is increased. 
The major spectral shiftings observed for the aspirin in- 
plane vibrations, are also characteristics of drug interaction 
via anion specific donor sites. The infrared bands at 1760, 
1753, 1692, 1561, 1467, 1431, 1345, 1122, 1028 cm -1 assigned 
to the free drug in-plane C = O, O-C-O and C = C, C-O and 
C-C stretching vibrations [10], exhibited major shiftings, upon 
DNA complexation (Fig. 1, r = 1). The observed spectral 
changes are evidence for a major aspirin-DNA interaction 
through drug C=-O, COOCH3 and C-O groups. Similarly, 
the Raman lines at 1766, 1699, 1608, 1465, 1200 and 962 
cm -1 related to the aspirin C-.O, OCO, C-C,  C-O and C- 
C vibrations exhibited major shirtings in the spectra of drug- 
DNA complexes (Fig. 3). The observet~ Raman spectral dif- 
ferences are also characteristics of aspirin-DNA complexation 
through drug C-= O and C-O donor atoms. Similar behaviors 
were observed in the infrared and Raman spectra of the as- 
corbate-DNA complexes, where drug binding was through 
anion C-= O, C-O and OH donor atoms [10]. The calculated 
intensity ratios for DNA bases and the phosphate vibrations 
show major drug-DNA binding via nucleobases (50%) with 
respect to the drug-PO2 interaction (30%) at high aspirin con- 
centration (Fig. 2, r = 1). 
In conclusion, the spectroscopic results presented here for 
the first time, clearly show that at low drug concentration 
(r = 1/40), aspirin anion binding is mainly through the back- 
bone PO2 groups and the A-T bases (such as adenine N-7 and 
thymine 0-2 atoms that are not involved in W-C hydrogen 
bonding network). As drug concentration i creases (r > 1/ 
20), aspirin binding extends to guanine bases (N-7 site). 
This type of complexation does not cause helix perturbation. 
However, at high aspirin content (r > 1/2), drug binding to 
A,T,G,C bases occurs with a partial helix destabilization. As- 
pirin-DNA complexation causes a partial reduction of the B- 
DNA structure in favor of A-DNA. 
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